1 Death or CLD |
4 |
439 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.66 [0.56, 4.94] |
1.1 < 28 weeks |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
1.2 28 ‐ 32 weeks |
1 |
37 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.55 [0.29, 22.31] |
1.3 ≥ 32 weeks |
1 |
88 |
Risk Ratio (M‐H, Fixed, 95% CI) |
6.54 [0.32, 132.33] |
1.4 < 37 weeks' (subgroup data not available) |
3 |
314 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.76 [0.15, 3.77] |
2 CLD |
4 |
439 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.07 [0.64, 6.64] |
2.1 < 28 weeks |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.2 28 ‐ 32 weeks |
1 |
37 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.55 [0.29, 22.31] |
2.3 > 32 weeks |
1 |
88 |
Risk Ratio (M‐H, Fixed, 95% CI) |
6.54 [0.32, 132.33] |
2.4 < 37 weeks' (subgroup data not available) |
3 |
314 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.06 [0.19, 5.97] |
3 Death |
4 |
439 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.36 [0.01, 8.73] |
3.1 < 28 weeks |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
3.2 28 ‐ 32 weeks |
1 |
37 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
3.3 > 32 weeks |
1 |
88 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
3.4 < 37 weeks' (subgroup data not available) |
3 |
314 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.36 [0.01, 8.73] |
4 Treatment failure within 7 days of trial entry |
4 |
439 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.30 [0.73, 2.34] |
4.1 < 28 weeks |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
4.2 28 ‐ 32 weeks |
1 |
37 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.17 [0.01, 3.34] |
4.3 > 32 weeks |
1 |
88 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.13 [0.41, 3.08] |
4.4 < 37 weeks' (subgroup data not available) |
3 |
314 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.77 [0.81, 3.89] |
5 Intubation within 7 days of trial entry |
2 |
247 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.38 [0.86, 6.57] |
6 Intubation at any time point after trial entry |
1 |
125 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.16 [0.49, 2.71] |
7 Duration of any respiratory support (days) |
2 |
192 |
Mean Difference (IV, Fixed, 95% CI) |
0.97 [0.08, 1.86] |
8 Duration of supplemental oxygen (days) |
1 |
125 |
Mean Difference (IV, Fixed, 95% CI) |
3.70 [‐0.66, 8.06] |
9 Duration of hospitalisation (days) |
3 |
262 |
Mean Difference (IV, Fixed, 95% CI) |
0.50 [‐0.55, 1.56] |
10 Pneumothorax |
3 |
369 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.54 [0.17, 1.79] |
11 Nosocomial sepsis |
4 |
439 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.29 [0.66, 2.54] |
12 Gastrointestinal perforation or severe NEC |
1 |
125 |
Risk Ratio (M‐H, Fixed, 95% CI) |
3.46 [0.14, 83.27] |
13 Days to full feeds |
2 |
195 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.41 [‐1.46, 0.63] |
14 Nasal trauma |
3 |
258 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.62 [0.34, 1.15] |